Symposium: Development of Deoxynucleoside Therapy for Thymidine Kinase 2 Deficiency (TK2d) 


HOME PAGE COMMITTEE MITONICE COMMITTEE MYOLOGY COMMITTEE PROGRAMS TIMETABLE MYOLOGY MITONICE ABSTRACTS REGISTRATION TO REGISTER GROUP SPACE PERSONAL SPACE USEFUL INFORMATION VENUE AND ACCESS ACCOMMODATION CONTACT US OUR SPONSORS MYOLOGY CONGRESS MitoNice CONGRESS ABSTRACT BOOKS ABSTRACT BOOK MITONICE ABSTRACT BOOK MYOLOGY
Symposium: Development of Deoxynucleoside Therapy for Thymidine Kinase 2 Deficiency (TK2d)  Thursday, September 15, 2022 SYMPO • 15-PM-SYMPO • 6:00 PM > 7:00 PM • Symposium: Development of Deoxynucleoside Therapy for Thymidine Kinase 2 Deficiency (TK2d)  • Apollon Auditorium • SYMPL1 • Clinical overview and Natural History Spectrum of TK2d > C. Caterina GARONE (Bologna, Italy) • SYMPL2 • Pharmacological and Gene Therapy in TK2 mutant mice > C. Carlos LOPEZ-GOMEZ (Malaga, Spain) • SYMPL3 • Contributions of a Spanish Network to TK2d diagnosis and therapy > C. Cristina DOMÍNGUEZ-GONZÁLEZ (Madrid, Spain) • SYMPL4 • Expanded Access Deoxynucleos(t)ide TK2d Therapy at a US Site > M. Michio HIRANO (New York, Usa)